Abstract
Retinoic acid inhibits transformation of cells by polyoma virus middle T oncoprotein. Inhibition of transformation results from a retinoic acid-dependent failure of cells to fully express the c-fos proto-oncogene. Retinoic acid prevents transactivation of the c-fos promoter by disrupting signaling between tyrosine kinases at the plasma membrane and trans-acting factors at the c-fos promoter. We used complementary genetic, biochemical and molecular approaches to demonstrate that: (1) phosphatidylinositol 3-kinase signaling is the principle mechanism of polyoma virus middle T oncoprotein activation of c-fos expression; (2) middle T/phosphatidylinositol 3-kinase transactivation of the c-fos promoter and transformation of cells requires activation of both the small GTP-binding protein Rac and Jun N-terminal kinase; (3) retinoic acid inhibits activation of Jun N-terminal kinase, thereby preventing c-fos transactivation and transformation; and (4) middle T activation of c-fos transcription requires both the serum response element and the promoter proximal cyclic AMP response element. These studies identify a novel target through which retinoids prevent oncogenic transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alberto AS, Geneste O and Treisman R. . 1998 Cell 92: 475–487.
Bronson R, Dawe CJ, Carroll J and Benjamin T. . 1997 Proc. Natl. Acad. Sci. USA 94: 7954–7958.
Busam KJ, Roberts AB and Sporn MB. . 1992 J. Biol. Chem. 267: 19971–19977.
Caelles C, Gonzalez-Sanco JM and Munoz A. . 1997 Genes Dev. 11: 3351–3364.
Carmichael G, Schaffhausen BS, Mandel G, Liang TJ and Benjamin TL. . 1984 Proc. Natl. Acad. Sci. USA 81: 679–683.
Chambon P. . 1996 FASEB J. 10: 940–954.
Cheatham B, Vlahos CJ, Wang L, Blenis J and Kahn CR. . 1994 Mol. Cell. Biol. 14: 4902–4911.
Chen JD and Evans RM. . 1995 Nature 377: 454–457.
Chen JY, Penco S, Ostrowski J, Balaguer P, Pons M, Starrett JE, Reczek P, Chambon P and Gronemeyer H. . 1995 EMBO J. 14: 1187–1197.
Chou MM and Blenis J. . 1996 Cell 85: 573–583.
Chung J, Grammer TC, Lemon KP, Kazlauskas A and Blenis J. . 1994 Nature 370: 71–75.
Coso O, Chiariello M, Yu J, Teramoto H, Crespo N, Xu N, Miki T and Gutkind J. . 1995 Cell 81: 1137–1146.
Courtneidge SA and Smith AE. . 1983 Nature 303: 435–439.
Crespo P, Busteol XR, Aaronson DS, Coso OA, Lopes-Barahona M, Barbacid M and Gutkind JS. . 1996 Oncogene 13: 455–460.
Dahl J, Freund R, Blenis J and Benjamin TL. . 1996 Mol. Cell. Biol. 16: 2728–2735.
Derijard B, Raingeaud J, Barrett T, Wu I-H, Han J, Ulevitch RJ and Davis RJ. . 1995 Science 267: 682–685.
Dilworth SM, Brewster CEP, Jones MD, Lanfrancone L, Pelicci G and Pelicci PG. . 1994 Nature 367: 87–90.
Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang Z, Li X, Wan Y, Kang S and Voorhees JJ. . 1998 J. Clin. Invest. 101: 1432–1440.
Franke TF, Yang S, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN. . 1995 Cell 81: 727–736.
Franklin CC and Kraft AS. . 1995 Oncogene 11: 2365–2374.
Freund R, Dawe CJ, Carroll JP and Benjamin TL. . 1992a Am. J. Path. 141: 1409–1425.
Freund R, Sotnikov A, Bronson RT and Benjamin TL. . 1992b Virology 191: 716–723.
Glenn GM and Eckhart W. . 1993 J. Virol. 67: 1945–1952.
Gupta S, Barrett T, Whitmarsh A, Cavanagh J, Sluss H, Derijard B and Davis R. . 1996 EMBO J. 15: 2760–2770.
Gupta S, Campbell D, Derijard B and Davis RJ. . 1995 Science 267: 389–393.
Harvey R, Oostra BA, Belsham GJ, Gillett P and Smith AE. . 1984 Mol. Cell. Biol. 4: 1334–1343.
Hill C, Wynne J and Treisman R. . 1995 Cell 81: 1159–1170.
Hu Q, Kippel A, Muslin AJ, Fantl WJ and Williams LT. . 1995 Science 268: 100–102.
Janknecht R and Nordheim A. . 1996 Oncogene 12: 1961–1969.
Janknecht R, Ernst WH and Nordheim A. . 1995 Oncogene 10: 1209–1216.
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK and Rosenfeld MG. . 1996 Cell 85: 403–414.
Khuri FR, Cho Y and Talmage DA. . 1996 Cell Growth Differ. 7: 595–602.
Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG and Glass CK. . 1995 Nature 377: 451–454.
Ling LG, Drucker BS, Cantley LC and Roberts TM. . 1992 J. Virol. 66: 1702–1708.
Mangelsdorf DJ, Umesono K and Evans RM. . 1994 The Retinoids: Biology, Chemistry and Medicine. 2nd edn. Sporn M, Roberts A and Goodman D (eds).. Raven Press: NY pp. 319–349.
Matrisian LM, Glaichenhaus N, Gesnel MC and Breathnach R. . 1985 EMBO J. 4: 1435–1440.
Means AL and Gudas LJ. . 1995 Ann. Rev. Biochem. 64: 201–233.
Meili R, Cron P, Hemmings BA and Ballmer-Hofer K. . 1998 Oncogene 15: 904–907.
Minden A and Karin M. . 1997 Biochim. Biophys. Acta. 1333: F85–F104.
Minden A, Lin A, Claret F, Abo A and Karin M. . 1995 Cell 81: 1147–1157.
Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL and Karin M. . 1994 Science 266: 1719–1723.
Monfar M, Lemon KP, Grammer TC, Cheatham L, Chung J, Vlahos CJ and Blenis J. . 1995 Mol. Cell. Biol. 15: 326–337.
Nagpal S, Athanikar J and Chandraratna RA. . 1995 J. Biol. Chem. 270: 923–927.
Nakanishi H, Brewer KA and Exton JH. . 1993 J. Biol. Chem. 268: 13–16.
Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C and Chambon P. . 1990 EMBO J. 13: 4443–4454.
Pfahl M. . 1993 Endocrine Rev. 14: 651–658.
Price MA, Cruzalegui FH and Treisman R. . 1996 EMBO J. 15: 6552–6563.
Rameh LE and Armelin MCS. . 1991 Oncogene 6: 1049–1056.
Raptis L, Marcellus R, Corbley MJ, Krook A, Whitfield J, Anderson SK and Haliotis T. . 1991 J. Virol. 65: 5203–5210.
Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD and Downward J. . 1996 EMBO J. 15: 2442–2451.
Schaffhausen B and Benjamin TL. . 1981 J. Virol. 40: 184–196.
Schule R, Rangarajan P, Yang N, Kliewer S, Ransone L, Bolado J, Verma IM and Evans RM. . 1991 Proc. Natl. Acad. Sci. USA 88: 6092–6096.
Smith MR, DeGudicibus SJ and Stacey DW. . 1986 Nature 320: 540–543.
Soprano DR, Chen LX, Wu S, Donigan AM, Borghaei RC and Soprano KJ. . 1996 Oncogene 12: 577–584.
Srinivas S, Schonthal A and Eckhart W. . 1994 Proc. Natl. Acad. Sci. USA 91: 10064–10068.
Su W, Liu W, Schaffhausen B and Roberts TM. . 1995 J. Biol. Chem. 270: 12331–12334.
Talmage DA, Blenis J and Benjamin TL. . 1988 Mol. Cell. Biol. 8: 2309–2315.
Talmage DA, Freund R, Young AT, Dahl J, Dawe CJ and Benjamin TL. . 1989 Cell 59: 55–65.
Talmage DA and Lackey RS. . 1992 Oncogene 7: 1837–1845.
Talmage DA and Listerud MD. . 1994 Oncogene 9: 3557–3563.
Treisman R. . 1996 Curr. Opin. Cell. Biol. 8: 205–215.
Urich M, El Shemerly M, Besser D, Nagamine Y and Ballmer-Hofer K. . 1995 J. Biol. Chem. 270: 29286–29292.
Urich M, Senften M, Shaw PE and Ballmer-Hofer K. . 1997 Oncogene 14: 1235–1241.
Wasylyk C, Imler JL and Wasylyk B. . 1988 EMBO J. 7: 2475–2483.
Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA and Muller WJ. . 1998 Mol. Cell. Biol. 18: 2344–2359.
Xu X, Heidenreich O, Kitajima I, McGuire K, Li Q, Su B and Nerenberg M. . 1996 Oncogene 13: 135–142.
Yi X, Peterson J and Freund R. . 1997 J. Virol. 71: 6279–6286.
Zullo J, Stiles CD and Garcea RL. . 1987 Proc. Natl. Acad. Sci. USA 84: 1210–1214.
Acknowledgements
The authors would like to thank Drs A Minden, R Prywes, J Blenis and G Viglianti for plasmids and other reagents and Dr Audrey Minden for comments on the manuscript. These studies were supported by grants from the American Cancer Society (RPG95-024-03-CN, to DAT), the American Institute for Cancer Research (to DAT); the Columbia Presbyterian Cancer Center (to DAT) and the National Institute of Health (CA63111 to RF).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, Y., Freund, R., Listerud, M. et al. Retinoic acid inhibits transformation by preventing phosphatidylinositol 3-kinase dependent activation of the c-fos promoter. Oncogene 18, 139–148 (1999). https://doi.org/10.1038/sj.onc.1202272
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202272
Keywords
This article is cited by
-
Cell transformation by the middle T-antigen of polyoma virus
Oncogene (2001)